Evangelos Liberopoulos

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 285 citations · Full text

Family Medicine, Metabolic Syndrome, Lipid Disorder +10

Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study

Vasilios G. Athyros, Dimitri P. Mikhailidis, Triantafyllos Didangelos et al. · Current Medical Research and Opinion · 2006 · 245 citations

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Martina De Marco, Christophe Stevens et al. · Atherosclerosis · 2018 · 228 citations · Full text

Family Medicine, Lipid Disorder, Primary Care +9

“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses

Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo et al. · Current Vascular Pharmacology · 2011 · 197 citations

Hyperlipidemia, European Panel, Obesity +19

Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study

Vasilios G. Athyros, D. P. Mikhailidis, Evangelos Liberopoulos et al. · Nephrology Dialysis Transplantation · 2006 · 184 citations